- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06252480
Effect of Various Intensities of tDCS on Dual Task Cognitive Functions in Normal Subjects
February 2, 2024 updated by: Subhasish Chatterjee, Maharishi Markendeswar University (Deemed to be University)
Effect of Various Intensities of tDCS on Dual Task Cognitive Functions in Normal Subjects: A Pilot Study
Transcranial Direct Current Stimulation (tDCS) is a neuroregulatory method that delivers a weak straight tendency to neuronal areas with the intention of changing the brain's basic metabolic processes.
Degradation of executive performance may not necessarily arise from cathodal stimulation, and vice versa for anodal stimulation.
Study Overview
Detailed Description
Total 48 samples were taken, were randomly allocated into an experimental group of 4 variance of different intensities of tDCS.
At F3 and F4, tDCS was applied to the desired region.
Electrodes were put in using the 10-20 EEG technique throughout the parietal cortex, with the current electrode being set on F3 area and control electrode being positioned on the F4 area.
For 20 minutes over three days per week for up to three weeks, current intensities of 0.5mA for group A, 1.0mA for group B, 1.5mA for group C, and 2.0mA for group D were administered.
when engaging in dual-task cognitive processes.
The groups are going to receive 9 sessions of tDCS treatment.
The MoCA and TMT scale was completed by samples before and after the intervention.
Finally, specifics investigation will be carried out using SPSS 26.0 software.
Study Type
Interventional
Enrollment (Estimated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elina Osik, BPT
- Phone Number: 7629956147
- Email: elinaosik18@gmail.com
Study Contact Backup
- Name: Elina Osik, BPT
- Phone Number: 7629956147
- Email: elinaosik@gmail.com
Study Locations
-
-
Haryana
-
Ambala, Haryana, India, 133207
- Recruiting
- MMIPR
-
Contact:
- Subhashish Chatterjee, MPT(NEURO)
- Phone Number: +918950037407
- Email: subhasishphysio@gmail.com
-
Principal Investigator:
- Subhashish Chatterjee, MPT
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Physically healthy students only
- Willing to participate in the study
Exclusion Criteria:
- Any recent trauma or injury on the head of subjects
- If contact with the scalp is not possible
- Any resonant implant close to electrode placement site
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensities of tDCS and dual task cognitive functions
We have done in a one arm type.
The participants are divided into different intensity group (0.5 mA, 1.0 mA, 1.5 mA and 2.0 mA).
|
4 variance of different intensities of tDCS (0.5mA, 1 mA, 1.5mA and 2mA).
At F3 and F4, tDCS was applied to the desired region.
Electrodes were put in using the 10-20 EEG technique throughout the parietal cortex, with the current electrode being set on F3 area and control electrode being positioned on the F4 area.
For 20 minutes over three days per week for up to three weeks, current intensities of 0.5mA for group A, 1.0mA for group B, 1.5mA for group C, and 2.0mA for group D were administered.
when engaging in dual-task cognitive processes.
The groups are going to receive 9 sessions of tDCS treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MoCA
Time Frame: 10 mins
|
A quick test for minor cognitive impairment.
It evaluates a variety of cognitive processes, including executive functioning, recall, speech and direction.
The assessment has 30 points and requires 10 mins to finish for each person.
A typical result is that 26 and more is normal.
|
10 mins
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
TRAIL MAKING TEST
Time Frame: 3 minutes
|
TMT part A includes 25 rounds containing the digits 1 to 25 scribbled haphazardly within every round on a sheet of paper.
TMT part B similarly includes 25 rounds on a sheet of paper, but this rounds includes digits (1-12) and alphabet (A-L) instead of only being digits.
|
3 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Subhashish Chatterjee, MPT(NEURO), Maharishi Markendeshwar Institute of Physiotherapy and Rehabilitation, Ambala, Haryana, 133207
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Estimated)
February 10, 2024
Study Completion (Estimated)
March 10, 2024
Study Registration Dates
First Submitted
February 2, 2024
First Submitted That Met QC Criteria
February 2, 2024
First Posted (Actual)
February 9, 2024
Study Record Updates
Last Update Posted (Actual)
February 9, 2024
Last Update Submitted That Met QC Criteria
February 2, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- SPC-PA-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Functions
-
Mansoura UniversityNot yet recruitingCognitive Functions
-
Foundation University IslamabadCompletedBalance | Cognitive FunctionsPakistan
-
Gazi UniversityCompletedPostoperative Cognitive FunctionsTurkey
-
Scale Media IncCitruslabsCompletedSexual Function | Testosterone | Cognitive FunctionsUnited States
-
Bahçeşehir UniversityCompletedGeriatrics | Balance | Dual Task | Functionality | Cognitive FunctionsTurkey
-
Swiss Federal Institute of TechnologyCompletedEffects of Exergaming on Cognitive Functions in Young AthletenSwitzerland
-
Cemre AydeğerActive, not recruitingChemotherapy | Cognitive Functions | BDNFTurkey
-
Bahçeşehir UniversityNot yet recruitingHealthy Participants | Cognition | Vagus Nerve Stimulation | Neuromodulation | Sex Differences | Cognitive Assessment | Executive Functions | taVNS
-
City University of Hong KongThe Hong Kong Society for the AgedRecruitingCognitive FunctionsHong Kong
-
Second Xiangya Hospital of Central South UniversityNot yet recruitingMigraine | Cognitive Functions | Cognitive | PFO
Clinical Trials on tDCS
-
Northeastern UniversityMassachusetts General Hospital; National Institute on Aging (NIA)Unknown
-
Hôpital le VinatierCompletedSchizophrenia | Auditory HallucinationsFrance, Tunisia
-
Universidad de AlmeriaSecretaría General de Universidades, Investigación y Tecnología, Junta de...Enrolling by invitationSubstance-Related DisordersSpain
-
Thorsten RudroffTerminatedMultiple Sclerosis | Neuropathic PainUnited States
-
Nachum Soroker, MDUnknown
-
University of MichiganNational Institute of Mental Health (NIMH)Completed
-
New York UniversityRecruiting
-
Tianjin Eye HospitalRecruiting
-
Universidade Federal de PernambucoCompleted
-
Bambino Gesù Hospital and Research InstituteCompleted